NCT04644302 is a clinical trial of microcirculation recording in Viral Pneumonia, sponsored by University Hospital Hradec Kralove.

Who is sponsoring NCT04644302?

NCT04644302 is sponsored by University Hospital Hradec Kralove.

What drugs are being tested in NCT04644302?

Interventions in NCT04644302: microcirculation recording.

What condition does NCT04644302 study?

NCT04644302 studies Viral Pneumonia, Sepsis.

Is NCT04644302 still recruiting?

NCT04644302 is currently completed. Last updated 30 September 2021.

Last reviewed 2021-09-30 · How we verify

NCT04644302

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Circulatory Coherence in COVID-19 and Non-COVID-19 Patients With Sepsis

Completed Last updated 30 September 2021

What this trial tests

trial testing microcirculation recording in Viral Pneumonia in 28 participants. Completed in 1 July 2021.

Timeline

1 February 2020

Primary endpoint
1 July 2021

1 July 2021

Quick facts

Lead sponsor	University Hospital Hradec Kralove
Status	Completed
Study type	OBSERVATIONAL
Enrollment	28
Start date	1 February 2020
Primary completion	1 July 2021
Estimated completion	1 July 2021
Sites	1 location across Czechia

Drugs / interventions tested

microcirculation recording

Conditions studied

Viral Pneumonia — all drugs for Viral Pneumonia →
Sepsis — all drugs for Sepsis →

Sponsor

University Hospital Hradec Kralove

Who can join

18 and older, any sex, with Viral Pneumonia or Sepsis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This prospective observational pilot study investigates circulatory coherence in patients with COVID and non-COVID sepsis by comparison of microcirculation, endothelial glycocalyx, and clinical course

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Viral Pneumonia

Currently open trials in the same condition.

NCT07238114 — Liver Cirrhosis Patients With Invasive Pulmonary Aspergillosis: in Depth Understanding Clinical Host Risk Factors · active not recruiting

Other University Hospital Hradec Kralove trials

Trials by the same sponsor.

NCT07415655 — Modulation of Cerebral Ischemia by Albumin · Phase 2 · not yet recruiting
NCT03644641 — The Influence of Prone Position for Spinal Surgery on Visual Acuity · NA · not yet recruiting
NCT06894927 — Hearing Screening in Adults Over 50 Years Old · NA · enrolling by invitation
NCT05399602 — The Role of Neurofilament Light (NfL) in Patients With Hydrocephalus · NA · completed
NCT06083233 — Role of Brain Specific Biomarkers in Hydrocephalus · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04644302 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University Hospital Hradec Kralove
Last refreshed: 30 September 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04644302.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing